Status:
COMPLETED
Isolation of Cell Free Fetal DNA From Spent Culture Medium and Its Potential Role for Preimplantation Genetic Diagnosis (PGD).
Lead Sponsor:
Damascus University
Conditions:
Females Undergoing PGD Technology for Medical Conditions
Eligibility:
FEMALE
22-44 years
Brief Summary
Preimplantation genetic testing for chromosomal screening is, at present, the most reliable method to assess the genetic status of preimplantation embryos. DNA isolated and amplified from trophectoder...
Detailed Description
Noninvasiveness is a common theme across medical specialties in the 21st century. In obstetrics, noninvasive prenatal testing provoked a paradigm shift in prenatal clinical practice through the sequen...
Eligibility Criteria
Inclusion
- At least two blastocysts suitable for PGD. Only embryos achieving a grade 1 (fragmentation less than 15%).
Exclusion
- All embryos do not achieve inclusion criteria as mentioned above.
Key Trial Info
Start Date :
May 18 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 23 2023
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT06084377
Start Date
May 18 2020
End Date
September 23 2023
Last Update
October 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Damascus University
Damascus, Syria